Claudiximab

A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer
Forbes
Mon, 06/20/16 - 10:18 am
ASCO 2016
Claudiximab
antibodies
Ganymed
stomach cancer
esophageal cancer